Navigation Links
Abnormal Heart Rhythm Controlled By Cholesterol Drugs

cardiomyopathy,defibrillitor,Statins, a group of commonly used cholesterol-lowering drugs, used by patients with enlarged hearts// (dilated cardiomyopathy) due to an anti-arrhythmic effect.

Scientists with the Multicenter defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation (definite) committee evaluated about 458 sudden cardiac deaths with cardiomyopathy due to a survival benefit and effect of Statin therapy. Among these about, 229 patients were randomly selected to get an implantable Cardioverter defibrillator to treat their abnormal heart rhythm.

However these devices are programmed to detect the abnormalities first, and to then deliver a shock to restore normal heart rhythm. On an average, 110 patients were found to take Statin, while 348 take drugs such as Lipitor, Pravachol and Zocor. Statin therapy pack a 78-percent reduced mortality rate for cardiac patients.

Dr. Jeffrey J. Goldberger of northwestern University in Chicago, reported a 39-percent lower mortality rate among patients who received a defibrillator and who were on statin therapy than other patients in a 2,000 days study.

There was only 1 sudden death from arrhythmia among the patients who were receiving Statins, compared with 18 patients who were not on Statins and they require a shock to correct an abnormal heartbeat when compared to statin takers. Statins' benefits are may be due to their cholesterol-lowering effects, and primarily due to anti-inflammatory effects, antioxidant effects or effects on the nervous system.


'"/>




Page: 1

Related medicine news :

1. Early Detection Of Facial Abnormalities in a Fetus
2. Abnormal Brain Structure One Of The Reasons For Depression in Adolescents
3. Antidepressants Could Lead To Abnormal Bleeding
4. Abnormal heart rate and depression may increase death risk
5. Opioids And Abnormal Pain Perception
6. Cancer Causing Proteins Trigger Abnormal Biochemical Reactions In Cells
7. Neglect In Childhood Could Cause Abnormal Behaviour In Adults
8. Detecting Brain Abnormalities in Babies Using New Brain Scanners.
9. New Abnormal Karyotypes Discovered in China
10. Brain Abnormalities Raise the Risk of PTSD
11. Medication Abuse In Chronic Migraine May Cause Hormonal Abnormalities
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: